By Mrinalika Roy and Sriparna Roy April 20 (Reuters) – The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and industry executives said, as retailers adjust product offerings to suit cha…
By Mrinalika Roy and Sriparna Roy April 20 (Reuters) – The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and industry executives said, as retailers adjust product offerings to suit cha… Read More

